Houlihan Lokey Advises AseraCare Hospice

Houlihan Lokey is pleased to announce that Homecare Preferred Choice, Inc., doing business as AseraCare Hospice (“AseraCare”), has been acquired by Amedisys, Inc. (“Amedisys”). The transaction closed on June 1, 2020.

Founded in 1994, AseraCare is a leading provider of hospice services, caring for more than 2,100 patients daily across 44 agencies in 14 states. With an executive office in Plano, Texas, and an administrative support center in Fort Smith, Arkansas, the company employs more than 1,200 hospice professionals across its offices and agencies. AseraCare operates hospice agencies in Alabama, California, Indiana, Iowa, Kansas, Minnesota, Mississippi, Missouri, Nebraska, North Carolina, Pennsylvania, South Carolina, Tennessee, and Wisconsin.

Founded in 1982 and headquartered in Baton Rouge, Louisiana, Amedisys is a publicly held, leading healthcare-at-home company delivering personalized home health, hospice, and personal care. More than 2,600 hospitals and 67,000 physicians nationwide have chosen Amedisys as a partner in post-acute care. With more than 21,000 employees in 480 care centers in 38 states and the District of Columbia, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 415,000 patients and clients in need every year.

This transaction further strengthens Houlihan Lokey’s leadership position in the hospice and homecare sector, having advised on six transactions in the past two years. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the country. In 2019, the group closed 27 transactions and was ranked the No. 1 advisor for all U.S. healthcare M&A transactions by Refinitiv (formerly known as Thomson Reuters). Houlihan Lokey's Healthcare Group has closed more than 300 M&A healthcare transactions since its inception.

Houlihan Lokey served as the financial advisor to AseraCare and assisted in initiating, structuring, and negotiating the transaction on its behalf.


You are about to leave
Houlihan Lokey's website

The link below leads to a website that is not
owned by Houlihan Lokey.

Continue to the external website,
close the window to remain on HL.com